Zometa 4mg injection

Zometa (Zoledronic acid) 4mg is an IV bisphosphonate used to treat bone complications caused by cancer. Zometa inhibits bone resorption that will help control hypercalcemia (high level of blood calcium), reduce bone pain, and prevent fractures caused by multiple myeloma or solid tumors.Key specifications and mode of administrationManufacture: Novartis PharmaDose/Route: Usually administered by 4mg intravenous infusion in at least 15 minutes. The medication should only be taken under a physician’s supervision and should not be self-administered. Frequency: Depends on the medical condition. Administered once every 3-4 weeks for bone complications of cancer or as a single dose for hypercalcemia